Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow Reinvestment Rate
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Reinvestment Rate of 1.45x as of June 2026, reinvesting $76.28 Million (capex $39.00K plus investments $76.24 Million) from operating cash flow of $52.57 Million. See AUPH FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aurinia Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Aurinia Pharmaceuticals Inc across 2 annual periods. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Aurinia Pharmaceuticals Inc (2024–2025)
Year-by-year capital reinvestment analysis for Aurinia Pharmaceuticals Inc. See AUPH financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | $32.77 Million | $135.66 Million | $252.00K | ▼ -72.9% |
| 2024 | 0.89x | $39.54 Million | $44.39 Million | $281.00K | — |